
|Articles|February 1, 2018
- Pharmaceutical Executive-02-01-2018
- Volume 38
- Issue 2
Pharmaceutical Executive, February 2018 Issue (PDF)
Click the title above to open the Pharmaceutical Executive February 2018 issue in an interactive PDF format.
Advertisement
Articles in this issue
over 8 years ago
Pharma's Image Fix: Lessons from the Fieldover 8 years ago
The Innovation Distinction: Biopharma's Reputational Passover 8 years ago
Valeant’s Northern Faceover 8 years ago
More New Drugs and Generics Reshape Pharma Marketsover 8 years ago
Leadership in All the Right Placesover 8 years ago
Industry Engine CheckAdvertisement
Advertisement
Advertisement
Trending on PharmExec
1
Trump Administration Preparing New Round of Medicaid Drug-Pricing Deals: Report
2
M&A Roundup: DualityBio & Genentech Enter Partnership to Develop Next Generation ADC’s, Teva Bids to Acquire Igalmi from BioXcel
3
Study Shows Link Between Zepbound and Lower Healthcare Costs in Adults Aged 55 and Up with Obesity: Report
4
Pharmaceutical Executive Daily: DualityBio and Teva Strike Major Biopharma Deals
5




